Bain Capital Life Sciences
Overview
Bain Capital Life Sciences invests in biopharmaceutical, medical device, diagnostic, and life science tool companies across the globe, with a focus on companies that drive medical innovation to improve the lives of patients with unmet medical needs.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HeartFlow | Mar 2025 | Convertible Debt | Co-investor |
| Kailera Therapeutics | Oct 2025 | Series B | Co-investor |
| Swixx BioPharma | Dec 2025 | Buyout/LBO | Co-investor |
| Imperative Care | Mar 2026 | VC Round | Co-investor |
| Amylyx Pharmaceuticals | Jul 2021 | Series C | Co-investor |
For institutional investors. Book with your work email.
Key People
Lei Meng
Managing Director
Matthew Calistri
Managing Director
Renjie Wang
Managing Director
Will Cozean
Managing Director
Adam M. Koppel
Partner
Amir Zamani
Partner
Nicholas Downing
Partner
Ricky Lijing Sun
Partner
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bain Capital Life Sciences based?
Bain Capital Life Sciences is headquartered in Boston, Massachusetts, United States.
When was Bain Capital Life Sciences founded?
Bain Capital Life Sciences was founded in 2016.
How many portfolio companies does Bain Capital Life Sciences have?
Bain Capital Life Sciences has 39 portfolio companies in Caplight's dataset.
What are some companies in Bain Capital Life Sciences's portfolio?
Portfolio companies visible on Caplight include HeartFlow, Kailera Therapeutics, Swixx BioPharma, Imperative Care, Amylyx Pharmaceuticals.
What was Bain Capital Life Sciences's most recent investment shown here?
Bain Capital Life Sciences's most recent investment in this portfolio sample was in Imperative Care in 2026.
What sectors does Bain Capital Life Sciences focus on?
Bain Capital Life Sciences focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does Bain Capital Life Sciences focus on?
Bain Capital Life Sciences typically invests at the MultiStage stage.
What is Bain Capital Life Sciences's AUM?
Bain Capital Life Sciences's assets under management are estimated between $500.0M and $1.0B.